Head and Neck Cancer Research - Penn State Cancer Institute
Head and Neck Cancer Research
Research into head and neck cancer at Penn State Cancer Institute is conducted by the dedicated head and neck cancer team. See current clinical trials and members of that team here.
Clinical Trials
Effect of oral black raspberry administration on oral cell DNA adducts in smokers
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
NRG HN009- Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Dysgeusia and Anosmia in Head and Neck Cancer Patients: Long Term Outcomes
ACR 3518: Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer
Exploring Factors Associated with Understanding Among Head and Neck Surgery Patients
NRG-HN014:
Randomized Phase III Trial Of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-Of-Care Treatment For Resectable Stage Iii/Iv Cutaneous Squamous Cell Carcinoma
Head and Neck Cells: Tissue Repository
Disease Team Members
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
 |
Melissa | Boltz | DO | ||
 |
David | Goldenberg | MD | ||
 |
Neerav | Goyal | MD, MPH | ||
 |
Jessyka | Lighthall | MD | ||
 |
Mitchell | Machtay | MD | ||
 |
Brian | Saunders | MD |
Research into head and neck cancer at Penn State Cancer Institute is conducted by the dedicated head and neck cancer team. See current clinical trials and members of that team here.
Effect of oral black raspberry administration on oral cell DNA adducts in smokers
The COVID-19 and Cancer Consortium (CCC19) Registry
Psychosocial Challenges and Educational/Occupational Aspirations of Adolescent/Young Adult Cancer Survivors
NRG HN009- Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Dysgeusia and Anosmia in Head and Neck Cancer Patients: Long Term Outcomes
ACR 3518: Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer
Exploring Factors Associated with Understanding Among Head and Neck Surgery Patients
NRG-HN014:
Randomized Phase III Trial Of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-Of-Care Treatment For Resectable Stage Iii/Iv Cutaneous Squamous Cell Carcinoma
Head and Neck Cells: Tissue Repository
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
|
Melissa | Boltz | DO | ||
|
David | Goldenberg | MD | ||
|
Neerav | Goyal | MD, MPH | ||
|
Jessyka | Lighthall | MD | ||
|
Mitchell | Machtay | MD | ||
|
Brian | Saunders | MD |